Jonathan Rubin - Mar 5, 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
SVP, Chief Medical Officer
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Stock symbol
SUPN
Transactions as of
Mar 5, 2025
Transactions value $
-$48,517
Form type
4
Date filed
3/5/2025, 04:14 PM
Previous filing
Feb 24, 2025
Next filing
Sep 12, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Tax liability -$10.4K -314 -2.83% $33.05 10.8K Mar 5, 2025 Direct F1
transaction SUPN Common Stock Tax liability -$19.1K -577 -5.35% $33.05 10.2K Mar 5, 2025 Direct F1
transaction SUPN Common Stock Tax liability -$19.1K -577 -5.65% $33.05 9.64K Mar 5, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units.